Results 11 to 20 of about 3,526 (144)
Release of choline by phospholipase D and a related phosphoric diester hydrolase in human erythrocytes. 1H spin-echo n.m.r. studies [PDF]
A previously detected phosphatidylcholine-specific phospholipase D from lysates of human red blood cells has been further characterized by 1H spin-echo n.m.r. spectroscopy. A second choline-releasing enzymic activity was observed after addition of glycerophosphocholine.
H, Selle, B E, Chapman, P W, Kuchel
openaire +3 more sources
Changes in total phospholipids and activities of two phosphoric diester hydrolases,i.e. phospholipase C and phospholipase D have been studied in inoculated wheat leaves of 25-day old plants, interacting differentially with three races of brown rust,Puccinia recondita, during early stages of pathogenesis.
R. S. Saini +2 more
openaire +2 more sources
Development of covalent inhibitors: Principle, design, and application in cancer
The noncysteine covalent inhibitors are a class of small molecule inhibitors that can bind irreversibly to their target enzymes through covalent bonding with noncysteine residues. They have shown promise as potential therapeutics for a variety of diseases, including cancer, infectious diseases, and autoimmune disorders. Examples of noncysteine covalent
Lang Zheng +6 more
wiley +1 more source
Transcriptional responses of plants to As (V) stress [PDF]
Background Arsenic is toxic to plants and a common environmental pollutant. There is a strong chemical similarity between arsenate [As (V)] and phosphate (Pi).
Abercrombie, Jason M. +6 more
core +5 more sources
Genome of the house fly, L., a global vector of diseases with adaptations to a septic environment [PDF]
Background: Adult house flies, Musca domestica L., are mechanical vectors of more than 100 devastating diseases that have severe consequences for human and animal health.
Beukeboom, Leo W +25 more
core +7 more sources
Although various types of biopharmaceuticals have presented multidimensional therapeutic effects in spinal cord injury (SCI), the rigorous microenvironment after SCI impedes their capacity. Biomaterial‐based defenders (BBDs) are designed to protect biopharmaceuticals passively or actively to reduce their inactivation and loss.
Xunqi Zhang +3 more
wiley +1 more source
Abstract For hundreds of years, the color diversity of Mollusca shells has been a topic of interest for humanity. However, the genetic control underlying color expression is still poorly understood in mollusks. The pearl oyster Pinctada margaritifera is increasingly becoming a biological model to study this process due to its ability to produce a large
Pierre‐Louis Stenger +4 more
wiley +1 more source
Integration of bioinformatics analysis and experimental validation, this study provides novel insights into miRNA related networks in LUAD. Plasma exosomal hsa‐miR‐103b, hsa‐miR‐29c‐5p and hsa‐miR‐877‐5p may be used as diagnostic biomarkers for early LUAD.
Jing Wu +6 more
wiley +1 more source
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Innate immune system responds to stimulus (bacteria, virus, lipopolysaccharide) firstly; nevertheless, exaggerated immune response results in a variety of inflammation‐related diseases. Epigenetic modifications including chromatin remodeling, DNA modifications, RNA modifications, Histone modifications, noncoding RNA, and regulate multiple signaling ...
Su Zhang +8 more
wiley +1 more source
We recently reported that HMGB1 showed a negative impact on anti‐tumor immunity, however, a positive role of HMGB1 in the initiation of innate and subsequent adaptive immunity has also been shown. In this study, we found that the suppression of HMGB1 in the tumor microenvironment does not inhibit the induction of neoantigen‐specific immunity.
Kayoko Waki, Miyako Ozawa, Akira Yamada
wiley +1 more source

